This announcement is a separate document:
北京市天元律师事务所关于昭衍新药2024年第一次临时股东大会、2024年第一次A股类别股东会议及2024年第一次H股类别股东会议的法律意见
Legal opinions of Beijing Tianyuan Law Firm on Zhaoyan New Pharmaceutical's 2024 First Extraordinary General Meeting of Shareholders, 2024 First Class A Shareholders' Meeting, and 2024 First Class H Shareholders' Meeting
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.